학술논문
Cost-effectiveness of budesonide-formoterol vs inhaled epinephrine in US adults with mild asthma
Document Type
Article
Author
Source
Annals of Allergy, Asthma & Immunology; February 2024, Vol. 132 Issue: 2 p229-239.e3
Subject
Language
ISSN
10811206
Abstract
The management of mild asthma has lacked an over-the-counter (OTC) option aside from inhaled epinephrine, which is available in the United States. However, inhaled epinephrine use without an inhaled corticosteroid may increase the risk of asthma death.